If advertisements do not include complete scientific information, treatment decisions may be influenced by incomplete evidence
Monitoring, Dose Adjustment, and When to Pause Treatment Warning signs include persistent severe nausea, vomiting that prevents food or fluid intake, abdominal bloating unrelieved by position change, or inability to tolerate any oral intake after two weeks of stable dosing
Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from l cells and alpha cells
Nitrofurantoin, for example, should be taken with food but may cause nausea in some people
Also likely, she said, is that some of those who are new to GLP-1s under the Bridge program will experience what 10% or more of all GLP-1 users run into: nausea, vomiting, diarrhea and other gastrointestinal side effects that cause them to discontinue using the drug or taper their dose
Yet with more options have come more questions, especially around safety, support and value for money
